Authors: Jennifer Miles, Peter Treitler, Richard Hermida, Amesika N. Nyaku, Kosali Simon, Sumedha Gupta, Stephen Crystal, Hillary Samples
Medicare disability beneficiaries (MDBs) have disproportionately high risk of opioid use disorder (OUD) and related harms given high rates of comorbidities and high-dose opioid prescribing. Despite this increased risk, little is known about timely receipt of medication for opioid use disorder (MOUD), including potential disparities by patient race/ethnicity or moderation by county-level characteristics.
